NCT03292926View on ClinicalTrials.gov

A Novel Analgesia Technique for ACL Reconstruction

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

March 6, 2020

Study Completion Date

April 16, 2020

Conditions
Anterior Cruciate Ligament Injury
Interventions
DRUG

Bupivacaine

Bupivacaine will help treat pain and sensation after ACL repair

DEVICE

Ultrasound

Ultrasound will guide anesthesiologist in performing the different nerve blocks

DRUG

Dexamethasone

Dexamethasone will be used to prolong block duration

Trial Locations (1)

10023

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER

NCT03292926 - A Novel Analgesia Technique for ACL Reconstruction | Biotech Hunter | Biotech Hunter